Delineation of Clavispora lusitaniae clinical isolates by polymerase chain reaction - Single strand conformation polymorphism analysis of the ITSI region: A retrospective study comparing five typing methods

Medical Mycology

Volumn 42, Issue 1, 2004, Pages 27-34

  Arabatzis, M ^a   Kollia, K ^a   Menounos, P ^b   Logotheti, M ^a   Velegraki, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Molecular Biology Laboratory   (Greece)

Author keywords

Clavispora lusitaniae; Infections; ITS1; Molecular typing; PCR SSCP

Indexed keywords

ANTINEOPLASTIC AGENT; RIBOSOME DNA;

AMPLICON; ARTICLE; CHROMOSOME; CLAVISPORA LUSITANIAE; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; HEAD AND NECK TUMOR; HOSPITAL; HUMAN; INTERMETHOD COMPARISON; KARYOTYPING; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTPATIENT; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RNA FINGERPRINTING; SINGLE STRAND CONFORMATION POLYMORPHISM; YEAST;

AMINO ACID SEQUENCE; DNA, RIBOSOMAL SPACER; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MYCOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETROSPECTIVE STUDIES; SACCHAROMYCETALES;

CLAVISPORA; CLAVISPORA LUSITANIAE; FUNGI;

EID: 0842329654     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/1369378032000141444     Document Type: Article

References (29)

1. Papagiannis D, Collins MS, Hector R, Remington J. Development of resistance in amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 1979; 16: 123-126.
2. Merz WG. Candida lusitaniae: Frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 1984; 20: 1194-1195.
3. Merz WG, Khazan U, Jabra-Risk MA, Wu LC, Osterhout GJ. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J Clin Microbiol 1992; 30: 449-454.
4. Nguyen MH, Peacock JE Jr., Morris AJ et al. The changing face of candidemia; Emergence of non-C. albicans species and antifungals resistance. Am J Med 1996; 100: 617-623.
5. Sanchez V, Vazquez JA, Barth-Jones D, et al. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 1992; 30: 3005-3008.
6. Fowler SL, Rhoton B. Springer SC et al. Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1998; 19: 343-345.
7. King D, Rhine-Chalberg J, Pfaller MA, Moser SA, Merz WG. Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol 1995; 33: 1467-1470.
8. Lehmann PF, Lin D, Lasker BA. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 1992; 30: 3249-3254.
9. Lachance MA, Phaff HJ. Descriptions of teleomorphic ascomycetous gener and species. Clavispora Rodriguez de Miranda. In: Kurtzman CP, Fell JW (eds). The Yeasts, a Taxonomic Study, 4th edn. Amsterdam: Elsevier Science, 1998: 148-152.
10. Kanellopoulou M, Stamos G, Petinelli I, et al. Subtyping and antifungal susceptibilities of Candida spp in the intensive care unit of a Greek general hospital. Int J Antimicrob Agents 2001; 18: 179-183.
11. Velegraki, Kambouris M, Skiniotis G et al. Identification of medically significant fungal genera with PCR followed by restriction enzyme analysis FEMS Immunol Med Microbiol 1999; 23: 303-312.
12. Meyer W, Mitchell TG. Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: Strain variation in Cryptococcus neoformans. Electrophoresis 1995; 16: 1648-1656.
13. Burns TT, White TJ, Taylor JW. Fungal molecular systematics. Annual Rev Ecol Systemat 1991; 22: 525-564.
14. Chakrabati R, Schutt C. The enhancement of PCR amplification by low molecular weight amides. Nucleic Acids Research 2001; 29: 2377-2381.
15. Blinkhorn RJ, Adelstein D, Spanguolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol 1989; 27: 236-240.
16. Pfaller MA. Nosocomial candidiasis: Emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996; 22 (Suppl.): 589-591
17. Ellis D. Amphotericin B: Spectrum and resistance. J Antimicrob Chemother 2002; 49(Suppl. 1): 7-10.
18. Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987; 9: 1006-1012.
19. Yoon SA, Vazquez JA, Stefan PE, Sobel JD, Akins RA. High frequency in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother 1999; 43: 836-845.
20. Xu J, Boyd CM, Livingston E, et al. Species and genotypic diversities and similarities of pathogenic yeasts colonizing women. J Clin Microbiol 1999; 37: 3835-3843.
21. Riederer K, Fozo P, Khatib R. Typing of Candida albicans and Candida parapsilosis: Species-related limitations of electrophoretic karyotyping and restriction endonuclease analysis of genomic DNA. Mycoses 2001; 8: 397-402.
22. Diaz-Guerra TM, Joaquin V, Suarez M, Laguna F, Rodriguez-Tudela SL. Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus - Positive patients with oral candidiasis. J Clin Microbiol 1997; 35: 856-861.
23. Steffan P, Vazquez JA, Boikov D, et al. Identification of Candida species by Random Amplified Polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol 1997; 35: 2031-2039.
24. Vazquez JA, Beckley A, Sobel J, Zervos MJ. Comparison of restriction enzyme analysis and Pulsed-field Gradient Gel Electrophoresis as typing systems for Candida albicans. J Clin Microbiol 1991; 29: 962-967.
25. Velegraki A, Menounos PG, Toukas D et al. Typing clinical isolates of Cryptococcus neoformans by PCR-SSCP (Abstract PO2). Abstracts of the Fifth International Conference: Cryptococcus and Cryptococcosis, Adelaide, Australia, 3-7 March 2002.
26. Kaiser R, Tremblay P-B, Roots I, Brockmöller J. Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 2002; 35: 49-56.
27. Meyer W, Maszewska K, Sorrell TC. PCR fingerprinting: A convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol 2001; 39: 185-193.
28. St-Germain G, Laverdière M, Pelletier R et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2-year (1996-1998) multicentre surveillance study in Quebec, Canada. J Clin Microbiol 2001; 39: 949-953.
29. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-260.